S02 - Continuous Glucose Monitoring Use in Type 2 Diabetes: Pearls for Your Practice

Saturday, August 5, 2023

9:45 AM – 10:30 AM CT

Location: Ballroom B

CE/CME Hours: 0.75

CE/CME Hours: .75
Pharmacology Hours: 0.0
Activity Type: Knowledge-based
UAN: JA4008258-9999-23-137-L01-P
CHES/MCHES: .75

Today there are multiple continuous glucose monitoring (CGM) devices available to help manage type 2 diabetes (T2D) in patients who are taking insulin. This technology has been proven to decrease risk of hyperglycemia and hypoglycemia and increase time in target range. In this live Town Hall, experts in diabetes will review recently published clinical data on the efficacy and safety of CGM in T2D. In addition, using case-based dialogue, faculty will discuss CGM data interpretation, patient education, and practical tips and pearls to help you successfully use new technologies safely and effectively in your practice. Please join us!

This program is supported by an independent educational grant from Abbott Diabetes Care.
This program is joint provided by the Association of Diabetes Care & Education Specialists and Medscape.

Pre-registration is appreciated: http://www.medscape.org/symposium/cgm_educators

Presenter(s)

Davida F. Kruger, MSN,APN-BC,BC-ADM

Nurse Practitioner
Henry Ford Health System
Grosse Pointe Farms, Michigan

Abbott Diabetes (Individual(s) Involved: Self; Products/Services: Diabetes): ; Beta Bionics (Individual(s) Involved: Self; Products/Services: Diabetes): ; CeQur (Individual(s) Involved: Self; Products/Services: Diabetes): ; Dexcom (Individual(s) Involved: Self; Products/Services: Diabetes): ; Eli Lilly (Individual(s) Involved: Self; Products/Services: Diabetes): ; embecta (Individual(s) Involved: Self; Products/Services: Diabetes): ; Insulet (Individual(s) Involved: Self; Products/Services: Diabetes): ; Mankind (Individual(s) Involved: Self; Products/Services: Diabetes): ; Medical Module (Individual(s) Involved: Self; Products/Services: Diabetes): ; Medtronics (Individual(s) Involved: Self; Products/Services: Diabetes): ; Novo Nordisk (Individual(s) Involved: Self; Products/Services: Diabetes): ; Provention Bio (Individual(s) Involved: Self; Products/Services: Diabetes): ; Sanofi (Individual(s) Involved: Self; Products/Services: Diabetes): ; Tandem Diabetes (Individual(s) Involved: Self; Products/Services: Diabetes): ; Xeris Pharmaceuticals (Individual(s) Involved: Self; Products/Services: Diabetes):
Amy Butts, PA-C, CDCES, BC-ADM

Endocrinology Physician Assistant
WVU Medicine Wheeling Hospital
MCDONALD, Pennsylvania

Abbott Diabetes (Individual(s) Involved: Self; Products/Services: Diabetes): ; Bayer (Individual(s) Involved: Self; Products/Services: Diabetes): ; Novo Nordisk (Individual(s) Involved: Self; Products/Services: Diabetes): ; Provention Bio (Individual(s) Involved: Self; Products/Services: Diabetes): ; Sanofi (Individual(s) Involved: Self; Products/Services: Diabetes): ; Xeris Pharmaceuticals (Individual(s) Involved: Self; Products/Services: Diabetes):
Eden M. Miller, DO

Director
Diabetes and Obesity Care LLC, Oregon

Disclosure(s): Abbott: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bayer: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); BI: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Eli Lilly: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Insulet: Consultant / Advisory Board (Ongoing); Novo Nordisk: Consultant / Advisory Board (Ongoing), Speakers' Bureau (Ongoing)